These results confirmed the target network pharmacology prediction from the perspective of the in vitro experiments and further showed that CKI plays a pharmacological role in cell cycle arrest in CRC cells by downregulating the expression of these targets, with the exception of p21. This evidence concerns the gene CHKA and colorectal carcinoma.